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Abstract: As surgical site infection can prolong the patient’s hospital stay, increase morbidity and mortality rates and medical and hospital
expenses, justifying the search for new effective and low-cost antiseptic drugs is justifiable. Thus, the objective of the present study was
to analyze, by direct clinical and microbiological examination, the topical antiseptic effect of a solution based on polyhexamethylene
hydrochloride guanidine (PHMGH) at 0.5% on the intact skin surface of sheep and cats, aiming at its use in operative field (previous and
definitive antisepsis), compared to 0.5% alcoholic chlorhexidine and association with this. The topical solutions did not cause any skin
damage, regardless of species. The PHMGH demonstrated an antiseptic effect equivalent to chlorhexidine, however, the association between
PHMGH and alcoholic chlorhexidine was more effective compared to isolated products. It is concluded that the topical products tested were
harmless to the skin surface; PHMGH can be a preventive and less expensive option in skin antisepsis and that the association between
PHMGH and alcoholic chlorhexidine was more effective in microbiological control when compared to the isolated products tested, however,
more research will be essential to investigate the potentiation of these, as well as the performance of PHMGH in the presence of body fluids.
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1. Introduction
Infections in the surgical field can prolong hospital stay
and increase patient morbidity and mortality, in addition
to increasing medical and hospital expenses [1–3]. In
this context, regardless of the species, the main source of
infection is the direct inoculation of the patient’s own skin
microbiota at the surgical site; thus, surgical interventions
must be necessarily initiated with the use of skin antiseptic
products in the incision area and adjacent regions, with
minimal damage and irritation, aiming at considerable
reduction of transient and resident microorganisms [4].
Chlorhexidine digluconate is the most commonly used
product for this purpose, and at high concentrations it
exerts a bactericidal function and, at low concentrations,
it acts as a bacteriostatic [5].
Despite advances in the pharmaceutical industry,
each medicament presents distinct therapeutic response
and side effect, none being fully effective. In addition,
it is considered that the common and indiscriminate
use of antiseptics in the health area can cause resistance

of microorganisms [4]. Thus, studies that propose the
investigation of new broad-spectrum drugs are justified
in the surgical area [6], aiming at promising and less
costly preventions; in this context, the synthetic polymer
polyhexamethylene hydrochloride guanidine (PHMGH)
[7,8] stands out, both for isolated use and in association
with established commercial products.
PHMGH is a cationic synthetic polymer from
the guanidine family, whose synthesis occurs by
polycondensation of hexamethylenediamine chloride
with dicyandiamide [9, 10]. Cationic polymers such as
guanidine-based polymers are of great interest and widely
used due to their high antibacterial and antiviral activity
and low toxicity to humans [11]. PHMGH is becoming
increasingly popular due to its broad range of antimicrobial
activity. This polymeric guanidine presents significant
antibacterial [12–14] and antifungal activities [15] in vitro
experimental models, and even at low concentrations,
demonstrates rapid and prolonged performance [10,16,17],
and no developed resistance has been reported [10].
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Guanidine polymer inhibits bacterial growth by
attacking them through electrostatic attraction between
cationic guanidio groups and anionic groups on the cell
surface of bacteria [18]. After attaching to bacteria cells,
guanidine polymer induces bacterial membrane collapsed
and intracellular components leaked thereafter [13].
PHMGH diffuses through the cellular membrane and binds
to the cytoplasmic membrane forming a complex with the
phospholipid molecules of the lipid bilayer, destabilizes
the osmotic equilibrium and destructs cytoplasmic
membrane, causing leakage of cell. It strongly reacts with
nucleic acid, in both cases creatingionic bindings with
monophosphate groups present in the bacterial cell and in
the nucleic acid [19].
Given the high number of elective and emergency
procedures and surgical complications, together with
the scarcity of scientific data on the in vivo activity of
polyhexamethylene guanidine hydrochloride, the objective
of this study was to analyze the topical and antiseptic effect
of a solution based on PHMGH at 0.5%, on intact skin
surface of sheep and cats, mimicking previous antisepsis
in operative sites. Also, this study aims to compare it
with commercial alcoholic chlorhexidine at 0.5% and
associate it with this same drug, aiming to analyze possible
potentiation of the products.
2. Material and methods
2.1. Obtention of the polymer and topical solutions
preparation
PHMGH (Akwaton) was provided by Fosfaton Akwaton
International Ltd. (Canada).
Two topical solutions were formulated, in one of them,
the polymer was diluted in deionized water to reach the
final concentration of 0.5% and in the other, added at this
same concentration to commercial alcoholic chlorhexidine
at 0.5% (Riohex - Indústria Farmacêutica Rioquímica
Ltda., São José do Rio Preto - SP).
The solutions were kept in a closed container at room
temperature.
2.2. Ethical aspects
The study protocol was approved by the Ethics Committee
on Animal Care of the University of Franca - UNIFRAN
(Approval no. 9968110518). The choice of animal species
was based on the different surgical environments normally
adopted in the operative routine of each one, in addition
to microorganisms in the surgical field. Furthermore, the
different body regions most accessed surgically in each
animal category were considered.
2.3. Experimental design
2.3.1. Sheep
Twenty-four Santa Inês sheep were used, male and female,
whole and castrated, of varying age and weight, from the
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Veterinary Hospital of UNIFRAN and kept in collective
pens, with water, commercial feed and hay ad libitum.
The inclusion criterion of animals in the research was
the absence of skin lesions diagnosed by direct clinical
inspection.
The experiment was carried out in the stalls,
mimicking the outdoor surgical environment, according
most procedures in this species, with the team involved
wearing a cap, mask, surgery pajamas and sterile gloves.
Without the use of anesthesia, the sheep were mechanically
restrained for extensive shaving of the left lateral region,
close to the flank, with the aid of a professional clipper.
2.3.2. Cats
Twenty-four male cats, intact, of varying age, breed and
weight, free of skin lesions, belonging to client tutors of the
UNIFRAN Veterinary Hospital, were used.
The experiment was conducted in the operating
room with the team involved wearing attire (cap, mask,
shoe cover, surgery pajamas, surgical gown and sterile
gloves). With the use of dissociative general anesthesia,
trichotomy of the middle third of the abdomen of all cats
was performed with a professional clipper.
Then, in all sheep and cats, a trichotomized area of 8 cm2
was delimited, proceeding with the basal microbiological
collections (M0) with a sterile swab in Stuart transport
medium (Olen - Model K41-0102, China).
Subsequently, antisepsis was performed on the
demarcated and intact areas, with sterile gauze soaked
in the tested topical formulations, recommending three
series/three times in each antimere, recommending from
the center to the edges. For this, both sheep and cats were
randomly distributed into four groups of six animals:
GPHMGH - group submitted to skin antisepsis with a
0.5% polyhexamethylene guanidine hydrochloride-based
solution; GCL - antisepsis with 0.5% commercial alcoholic
chlorhexidine; GPHMGH-CL - group submitted to skin
antisepsis with 0.5% polyhexamethylene hydrochloride
guanidine solution associated with 0.5% commercial
alcoholic chlorhexidine and GSF - untreated control
group: antisepsis with 0.9% saline solution (Brasmédica
S.A. Pharmaceutical Industry Ltd, São Paulo, Brazil).
After 1 min (M1), 5 min (M5), 10 min (M10), 40
min (M40) and 60 min (M60) of skin antisepsis with the
different products, microbiological samples were collected,
following the same criteria as M0.
2.4. Clinical analysis
The animals were inspected by direct clinical examination
for the presence or absence of dermal changes
(hyperemia, erythematous plaque, pruritus, among other
manifestations that expressed discomfort and/or adverse
reactions to dermal applications), resulting from the
action of the topical products tested. Clinical results were
expressed descriptively.
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2.5. Microbiological analysis
The microbiological samples from all analyzed
experimental moments were individually identified, sent
and processed, by blind study, at the Research Laboratory
in Applied Microbiology (LAPEMA) of UNIFRAN,
following conventional quantitative and qualitative
techniques [20].
2.5.1. Dilution of microbiological samples
For sample dilution, the swabs were immersed in test tubes
containing 3 mL of 0.9% saline solution (Brasmédica S.A.
Pharmaceutical Industry Ltd) for six consecutive hours
and incubated in aerobic conditions at 36.5 ºC overnight;
after that, an aliquot of 100 µL was transferred from
each tube to a tube containing 0.9 mL of saline solution,
carrying out an initial dilution of 10 times. In total, three
serial dilutions were performed on the scales of 10–1, 10–2
and 10–3, from the original undiluted sample (100).
From each dilution previously obtained, 100 μL of this
saline solution was placed in Petri dishes containing the
culture media (Merck KGaA, Darmstadt, Germany) Brain
and Heart Infusion (BHI) and MC Conkey (for aerobic
bacteria), blood agar (for microaerophiles) and Saboraud
Agar (for fungi and yeasts). The inoculated aliquots on
the plates were seeded by the spreading technique, with
the aid of a Drigalski loop and, after, for the growth of
aerobic bacteria, the culture media remained 48 h in an
aerobic oven, while for the microaerophilic they remained
in microaerophilic oven with 5% CO2 for 48 h. For fungal
growth, the plates were kept for seven days in an aerobic
oven, all incubated at 37 ºC.
2.5.2. Count of colony forming units per milliliter (CFU/
mL)
At the end of the incubation, a quantitative analysis of the
microorganisms was performed by counting the colony
forming units per milliliter (CFU/mL). For this, initially,
the colony growth homogeneity was evaluated in the three
dilutions obtained (10–1, 10–2 and 10–3).
At the lowest dilution scales, the colony forming units
were counted by estimation, requiring the division of the
Petri dish into four parts, where only one was counted and
multiplied by the remaining parts. At the end, the number
of CFU/mL was converted, according to the dilution used:
CFU/mL = number of colonies counted/sample dilution
factor × inoculated volume.
The fungal colonies were observed fresh and added a
drop of potassium hydroxide (Sigma-Aldrich St. Louis,
USA) in a small amount of colony. In addition, a drop of
cotton blue reagent (Sigma-Aldrich) was added to another
small amount of colony.
Quantitative assays were performed in triplicate and
results expressed in CFU/mL.

2.5.3. Colony isolation
After counting the CFU/mL, the colonies were isolated
and purified. For this, the Petri dishes with the greatest
morphological diversity were chosen and the visual
identification of the different morphotypes was performed
according to the colony characteristics, such as color,
border shape, size and texture of the colony.
Isolation was performed with the aid of a sterile
platinum loop, where a portion of the chosen morphotype
was transferred and seeded through the depletion
technique, in Brain and Heart Infusion culture medium
(BHI, Merck KGaA). The plates were identified according
to the description of the chosen morphotype, and
incubated under the same conditions as the processes
previously carried out. After the incubation time of the
plates, the growth and presence of morphotypes different
from the desired one was verified, and thus, the colony
purification process was carried out, where a well-isolated
portion of the colony was transferred from the isolation
plate and drained again in a plate containing Brain and
Heart Infusion medium (BHI, Merck KGaA), until a
completely pure colony was obtained.
These isolated colonies were stored in test tubes
containing Brain and Heart Infusion broth (BHI, Merck
KGaA) and stored aerobically at 36.5 °C for use in the
following stages of the study.
2.5.4. Identification of microorganisms
After the colony purification process, a qualitative analysis
of microorganisms was performed. For this, the isolates
were transferred to Petri dishes containing MacConkey
agar selective medium (Kasvi, São José dos Pinhais, Brazil)
to favor the growth of gram-negative microorganisms. The
plates were incubated in an inverted position at 36.5 °C
for 24 h, after which the reading was performed to assess
bacterial growth.
Qualitative analysis was performed semiautomatically,
using the BBL Crystal Enteric/Nonfermenter and BBL
Crystal Gram-Positive Kits (BD Life Sciences, East
Rutherford, NJ, USA) for gram-negative and gram-positive
bacteria, respectively.
For the identification procedure, pure isolates seeded
on Trypticase Soy Agar (Kasvi) with 5% sheep blood
(Laborclin, Pinhais, Paraná) were used. Thus, a well-isolated
colony (from 2 to 3 mm in diameter) of each morphotype
to be identified was selected with the aid of a sterilized
swab. Then, the selected colonies were transferred to tubes
containing the fluid for the preparation of the bacterial
suspension of each Kit, and the turbidity was performed,
corresponding to 0.5 on the McFarland scale.
Then, the inoculated panels were placed downwards in
an incubator without CO2, with 40% to 60% humidity, for
20 h for gram-negative bacteria and 24 h for gram-positive
bacteria. Reading was performed using the BBL Crystal
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Light Box (BD Life Sciences), following the specifications
of each Kit. The profile number of the isolates, obtained by
reading the BBL Crystal Light Box, as well as the results of
the necessary complements, was arranged in the BD BBL
Crystal MIND software to obtain the final identification.
Fungal colonies were analyzed under an optical
microscope (Leica Microsystems DMLB, Wetzlar,
Germany) in a 400x objective. Qualitative tests were
performed in triplicate and the results expressed in a
descriptive way.
2.6. Statistical analysis
Quantitative microbiological results from different times
and experimental groups were statistically compared
using the analysis of variance test (ANOVA) for repeated
measures, adopting a significance level of 5% (p ≤ 0.05),
using the Graphpad Prism 8.0 software.

< 0.001) and, during these periods, the tested products
showed considerable effectiveness, except for the saline
solution. In this context, in 50% of the GPHMGH sheep,
the product started to act after the M10 of the topical
application, while in the GCL sheep, only in the M40 and
M60. On the other hand, in all of the GPHMGH-CL, the
combination of topical products was 100% effective since
M10. Furthermore, the association between polymer and
commercial antiseptic was more promising in the control
of skin microorganisms, compared to isolated products
(Figure 1).
Up to M5, GPHMGH did not show a statistically
significant difference compared to GSF (p = 0.13), however,
in the subsequent microbiological analysis moments, this
difference was significant, indicating the antiseptic effect
of the synthetic polymer, even at low concentration (Table
1).
According to Table 1, at different times of analysis,
there was no significant statistical difference between
GPHMGH compared to GCL (p = 1.000), demonstrating
similar microbiological control of the polymer and the
commercial antiseptic. On the other hand, there was
a significant microbiological reduction of GPHMGHCL compared to GSF (p < 0.003), as well as GCL when
compared to GSF (p < 0.016).
3.2. Cats
3.2.1. Clinical
Similar to sheep, at different times, cats from all groups did
not show any cutaneous symptoms.
3.2.2. Microbiological
The qualitative microbiological assay, at different
experimental
times,
revealed
gram-positive

3. Results
3.1. Sheep
3.1.1. Clinical
No sheep showed skin symptoms secondary to the
application of topical products.
3.1.2. Microbiological
At different times of analysis, the qualitative microbiological
assay detected the presence of gram-positive bacteria
(Bacillus subtilis, Staphylococcus aureus, Corynebacterium
pseudotuberculosis,
Staphylococcus
saprophyticus,
Enterococcus faecalis, Staphylococcus epidermidis) and
yeasts (Rhodotorula sp).
Regarding the quantitative microbiological assay,
there was a statistically significant reduction in the
count of colony forming units at each analysis time (p

Colony-forming units (CFU/mL)

1

3,5
3
2,5
GPHMGH

2

GPHMGH-CL

1,5
1

GCL

0,5

GSF

0
0

1

5

10

40

60

Experimentals moments (min)

Figure 1. Graphic representation of colony forming units/mL in intact skin of 24 Santa Inês sheep, at baseline (0) and after 1, 5, 10, 40 and
60 min of skin antisepsis with different topical solutions. GPHMGH: group submitted to skin antisepsis with a 0.5% polyhexamethylene
guanidine hydrochloride-based solution (n = 6); GPHMGH-CL: skin antisepsis with the association of 0.5% polyhexamethylene
guanidine hydrochloride and 0.5% commercial alcoholic chlorhexidine (n = 6); GCL: skin antisepsis with 0.5% commercial alcoholic
chlorhexidine solution (n = 6) and GSF: skin antisepsis with 0.9% commercial saline solution (n = 6).
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Table 1. Means and standard deviations (M ± SD) of colony
forming units (mL) in intact skin of 24 Santa Inês sheep, at
baseline (M0) and after 1 (M1), 5 (M5), 10 (M10), 40 (M40) and
60 (M60) min of skin antisepsis with different topical solutions.
Moments
(min)

GROUPS (n=6)

M ± SD

M0

GPHMGH
GPHMGH-CL
GCL
GSF

2.333 ± 1.0
2.167 ± 0.4
1.667 ± 0.8
2.833 ± 0.9

M1

GPHMGH
GPHMGH-CL
GCL
GSF

3.000 ± 1.6
1.667 ± 0.8a
2.333 ± 0.5
2.833 ± 0.9

M5

GPHMGH
GPHMGH-CL
GCL
GSF

2.667 ± 1.7
1.000 ± 0.8a
1.500 ± 0.8a
2.667 ± 1.2

M10

GPHMGH
GPHMGH-CL
GCL
GSF

1.167 ± 1.6a
0 ± 0a
1.167 ± 0.4a
2.333 ± 1.2

M40

GPHMGH
GPHMGH-CL
GCL
GSF

0 ± 0a
0 ± 0a
0 ± 0a
2.500 ± 1.3

M60

GPHMGH
GPHMGH-CL
GCL
GSF

0 ± 0a
0 ± 0a
0 ± 0a
2.667 ± 1.2

GPHMGH: group submitted to skin antisepsis with a 0.5%
polyhexamethylene guanidine hydrochloride-based solution
(n = 6); GPHMGH-CL: skin antisepsis with the association of
0.5% polyhexamethylene hydrochloride guanidine and 0.5%
commercial alcoholic chlorhexidine (n = 6); GCL: skin antisepsis
with 0.5% commercial alcoholic chlorhexidine solution (n = 6)
and GSF: skin antisepsis with 0.9% commercial saline solution
(n = 6).
a
Significantly different from the GSF at each time point of
analysis (p ≤ 0.05).

(Corynebacterium
diphtheriae,
Staphylococcus
saprophyticus, Bacillus mentagrophytes, Staphylococcus
aureus and Gemella haemolysans) and Gram-negative
(Enterobacter sakazakii) bacteria.
Similar to sheep, there was a statistical reduction in the
count of colony forming units at each analysis time (p <
0.001) and the tested products were effective throughout
these periods, with the exception of saline solution.
In five cats (83.3%) of GPHMGH, the polymer began
to act on M10, identical to those of GCL. The combination

of products (GPHMGH-CL) significantly reduced
microorganisms by 66.7% in M1, being 100% effective in
M5 (Figure 2).
Similar to sheep, GPHMGH showed no statistical
difference compared to GSF up to M5, however, in the
following moments, the microbiological reduction was
discrepant, confirming the antiseptic characteristic of the
synthetic polymer.
Still equivalent to the results of sheep, in the feline
species there was no statistical difference of GPHMGH
in contrast to GCL at different times, demonstrating
microbiological similarity of both products. There was a
considerable statistical microbiological reduction between
GPHMGH-CL compared to GSF (p < 0.001), as well as
between GCL and GSF (p < 0.001). Furthermore, the
association between polymer and commercial antiseptic
was more promising in the control of skin microorganisms,
compared to isolated products (Table 2).
4. Discussion
Due to scarcity of scientific studies evaluating the
antiseptic effect of PHMGH in dermatology, combined
with its low cost and already demonstrated properties in
vitro [2,12,16,18], the current research aimed to evaluate,
by clinical and microbiological examination, the isolated
action of a topical solution containing a commercial
version of this compound at 0.5% (PHMGH - Akwaton)
and associate with commercial chlorhexidine at the same
concentration.
In view of the innumerable microorganisms involved
in skin microbiota, in vivo tests using different species
animals are indispensable in the investigation of new
dermatological products [21]. Thus, the choice of
experimental models was based on the high incidence
of elective and emergency surgical procedures in small,
medium and large animals, as well as postoperative
complications resulting from infections at the surgical
site [6]. Different resident skin microorganisms were
also considered, given the difference in maintenance and
handling of each animal species.
For shaving, a professional clipping machine was
chosen toavoid skin microlesions that could occur with
the use of a shaving blade, which could predispose the
resident microbiota to multiply, as reported by Silva et al.
[22]. In this sense, the established body regions aimed to
simulate the places commonly accessed surgically in the
selected species.
The choice of PHMGH in aqueous solution was
based on its high solubility in water, as well as to enable
comparison with the standard antiseptic of the market;
similar to concentration [2,10,12]. In this context,
Privitera et al. [1] reported that aqueous topical solutions
require more time to dry on the skin, however, in the study
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Figure 2. Graphic representation of colony forming units/mL in intact skin of 24 cats, at baseline (0) and after 1, 5, 10, 40 and 60
min of skin antisepsis with different topical solutions. GPHMGH: group submitted to skin antisepsis with a 0.5% polyhexamethylene
guanidine hydrochloride based solution (n = 6); GPHMGH-CL: skin antisepsis with the association of 0.5% polyhexamethylene
guanidine hydrochloride and 0.5% commercial alcoholic chlorhexidine (n = 6); GCL: skin antisepsis with 0.5% commercial alcoholic
chlorhexidine solution (n = 6) and GSF: skin antisepsis with 0.9% commercial saline solution (n = 6).

conducted here, such a time demand was not observed
in the GPHMGH animals that could interfere with the
preparation of the site to be later surgically manipulated.
When testing the antiseptic effect of 0.5% PHMGH on
experimentally induced superficial skin wounds in rats,
Dias et al. [23] observed that no animal treated showed
clinical toxicity symptoms, indicating that the polymer
can be harmless to the skin´s surface in this concentration,
corroborating the clinical results of this study. Although
alcoholic chlorhexidine has low irritability [4,24], Zhang
et al. [2] reported cutaneous clinical signs in humans
such as erythematous plaque, pruritus, and hyperemia;
on the other hand, in the current research, at the different
moments evaluated, the sheep and cats belonging to
the GPHMGH and GPHMGH-CL were asymptomatic,
indicating that the products based on the synthetic
polymer did not cause irritation and other local damage,
being innocuous to the skin surface. In addition, PHMGH,
because it is devoid of volatile organic compounds, is
odorless [12,14], a particularity that can minimize allergic
risks and local licks. Given the promising results found in
the in the present study, this product alone or associated
with alcoholic chlorhexidine can be used prior to the
insertion of intravenous catheters and injections of drugs,
both in animals and in humans, and not restricted to
surgical antisepsis.
According to the scientific literature [25,26], the
normal flora of cutaneous microorganisms of domestic
animals is diverse, depending on management, food and
habitat, including gram-positive, gram-negative bacteria
and fungi, thus justifying the realization of previous
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complementary exams to identify each one of them for
further microbiological tests using products that could
possibly be used in the future as antiseptics. In accordance
with the scientific literature, chlorhexidine showed gradual
efficacy against gram-positives [27], gram-negatives and
fungi [27], as well as PHMGH [2] and their association,
even at low concentrations [12,16,18] and against resistant
microorganisms, especially Staphylococcus aureus,
Enterococcus faecalis and Gemella haemolysans. They also
acted positively against the resistant and gram-negative
bacterium Enterobacter sakazakii, which has a double
outer membrane and, consequently, is more rigid, which
acts as a permeability barrier against some antiseptic
products [28], reducing its entry into the cytoplasm [12].
When investigating the 0.5% polymer in superficial
skin wounds experimentally induced in rats, Dias et al.
[23] observed that the product demonstrated the ability
to eliminate up to 100% of microorganisms until the
fourth day of treatment, whereas, in the intact skin of
sheep and cats, the complete reduction in colony-forming
unit counts occurred after minutes of the performance of
PHMGH, especially with its association with alcoholic
chlorhexidine. This polymer´s performance in short
periods has already been described by Koffi-Nevry et al.
[29], Mathurin et al. [7] and Oulé et al. [14], as well as
its prolonged residual effect [17], similar to that evidenced
until the last analyzed time of this study, probably due
to the substantivity power, remaining linked in its active
form to the cutaneous stratum corneum [1,30].
Casually, a slight increase in the number of cutaneous
microorganisms was observed in some groups of sheep
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Table 2. Means and standard deviations (M ± SD) of colony
forming units (mL) in intact skin from 24 cats, at baseline (M0)
and after 1 (M1), 5 (M5), 10 (M10), 40 (M40) and 60 ( M60) min
of skin antisepsis with different topical solutions.
Moments
(min)

GROUPS (n = 6)

M ± SD

M0

GPHMGH
GPHMGH-CL
GCL
GSF

1.500 ± 0.5
1.000 ± 0
1.667 ± 0.8
2.333 ± 0.5

M1

GPHMGH
GPHMGH-CL
GCL
GSF

1.500 ± 0.5
0.333 ± 0.5a
1.667 ± 0.8a
2.333 ± 0.5

M5

GPHMGH
GPHMGH-CL
GCL
GSF

1.500 ± 0.5
0 ±0a
1.500 ± 0.5a
2.333 ± 0.5

M10

GPHMGH
GPHMGH-CL
GCL
GSF

0.333 ± 0.8a
0 ± 0a
0.333 ±0.8a
2.333 ± 0.5

M40

GPHMGH
GPHMGH-CL
GCL
GSF

0 ± 0a
0 ± 0a
0 ± 0a
2.333 ± 0.5

M60

GPHMGH
GPHMGH-CL
GCL
GSF

0 ± 0a
0 ± 0a
0 ± 0a
2.333 ± 0.5

during the stipulated moments; this fact can be attributed
to the environmental conditions of experimental execution
(in the field), which favored microbial multiplication
[31], despite the fact that the team involved was correctly
outfitted. However, regardless of the animal species and
experimental location, PHMGH, when isolated, showed
progressive efficacy similar to alcoholic chlorhexidine
established in the human and veterinary market, and
the association between these products potentiated the
microbiological effects. Thus, such data propose that
the synthetic polymer, alone or in association, may be a
promising and less expensive option [12] in the control
of cutaneous microorganisms. In addition, there are no
reports of PHMGH antimicrobial resistance [32] and,
recently, some researchers from the same team [23]
described the absence of delayed healing, hepatotoxicity,
nephrotoxicity and toxicity after 21 days of using the
polymer in superficial skin wounds, experimentally
induced in rats.

The beneficial antimicrobial effects of PHMGH found
in the present work can be attributed to its mechanism
of action on the cell membrane [33,34] in promoting
inhibition of enzymes essential for microorganisms growth,
in addition to phospholipid degradation [17,35], with
coagulation of the cytosol and leakage of its cytoplasmic
content, with consequent cell death [10,12,18], which
were possibly potentiated when combined with alcoholic
chlorhexidine. Still in relation to the mechanism of action
of PHMGH, there is also evidence that once inside the
cell, the product binds to DNA and other nucleic acids,
damaging or inactivating the bacterial genetic material
[36]. In addition, Choi, Kim and Lee [16] reported that the
polymer acts on fungal plasma membranes inducing the
formation of pores, which cause loss of K+ ions followed by
contraction and cell death.
Also in relation to the effect of the polymer, Zhou et
al. [9] and Luo et al. [37] described that the PHMGH’s
antimicrobial action due to the presence of the flexible
linear alkyl chain in the polymer that improves the
partition capacity in the hydrophobic regions of the
phospholipid membranes, damaging the phospholipid
bilayer of the microorganisms.
In view of the results obtained in this work, future
research is essential to investigate the interaction and
physical-chemical stability [5] of the polymer with
alcoholic chlorhexidine and the probable potentiation of
chlorhexidine and/or of ethyl alcohol due to the addition
of PHMGH. It is still prudent to evaluate the antimicrobial
activity alone or in association with these products in the
presence of body fluids present during surgical procedures.
5. Conclusion
Based on the recommended methodology and the
results obtained, it is assumed that, clinically, topical
solutions based on polyhexamethylene hydrochloride
guanidine were innocuous on the intact skin surface
of animals. As for the antiseptic effect, regardless of the
experimental environment, the isolated polymer, even
at low concentration, showed similarity to commercial
alcoholic chlorhexidine, established in human and animal
medicine. Also, the microbiological effects obtained with
the association of the synthetic polymer with alcoholic
chlorhexidine were more promising compared to the
isolated products, justifying the need for future research to
investigate such potentiation.
The clinical and microbiological results further
perspectives in the development of novel products for
surgical field antisepsis, using PHMGH as an active
ingredient.
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